Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D King

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Pharmacology|July 1, 1997
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogsA A Parsons, S G Parker, P Raval, et al.
Psychopharmacology|January 1, 1993
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like propertiesT P Blackburn, G S Baxter, G A Kennett, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2001
Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT(6) receptorS M Bromidge, K Griffith, T D Heightman, et al.
Journal of Medicinal Chemistry|March 19, 1993
Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulantsF D King, M S Hadley, K T Joiner, et al.
Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)S M Bromidge, S E Clarke, T Gager, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonistsS M Bromidge, S Davies, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agentsS M Bromidge, S Dabbs, S Davies, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.
Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Pharmacology|July 1, 1997
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogsA A Parsons, S G Parker, P Raval, et al.
Psychopharmacology|January 1, 1993
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like propertiesT P Blackburn, G S Baxter, G A Kennett, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2001
Novel (4-piperazin-1-ylquinolin-6-yl) arylsulfonamides with high affinity and selectivity for the 5-HT(6) receptorS M Bromidge, K Griffith, T D Heightman, et al.
Journal of Medicinal Chemistry|March 19, 1993
Substituted benzamides with conformationally restricted side chains. 5. Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulantsF D King, M S Hadley, K T Joiner, et al.
Journal of Medicinal Chemistry|December 6, 1996
Synthesis, biological activity, and molecular modeling of selective 5-HT(2C/2B) receptor antagonistsI T Forbes, S Dabbs, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2001
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)S M Bromidge, S E Clarke, T Gager, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonistsS M Bromidge, S Davies, D M Duckworth, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2000
1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agentsS M Bromidge, S Dabbs, S Davies, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.
Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.
Pageof 3